Vandetanib is a quinazoline derivative with methoxy, bromo-fluorophenylamino, and piperidinylmethoxy substituents. It functions as an antineoplastic agent and tyrosine kinase inhibitor, primarily employed as an active pharmaceutical ingredient in targeted cancer therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vandetanib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Pazopanib
pharmaceutical raw material
Azathioprine
pharmaceutical raw material
Amifampridine phosphate
pharmaceutical raw material
GRF 1-29 (CJC1295)
pharmaceutical raw material
The international HS code for Vandetanib (CAS 443913-73-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
UHTHHESEBZOYNR-UHFFFAOYSA-N
CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC
Sourcing Vandetanib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.